Document is current
Any future updates will be listed below
-
Authors
Manivannan, Madhuri https://orcid.org/0009-0000-9156-9793
Jehanno, Charly https://orcid.org/0000-0002-2897-6027
Kloc, Michal https://orcid.org/0000-0002-4575-7723
Gomez Miragaya, Jorge https://orcid.org/0000-0003-1801-4681
Diepenbruck, Maren
Volkmann, Katrin
Coissieux, Marie-May https://orcid.org/0000-0001-5017-5253
Palafox, Marta
Rouchon, Adelin
Kramer, Nicolas
Schmidt, Alexander https://orcid.org/0000-0002-3149-2381
Blum, Yannick
Hamelin, Baptiste https://orcid.org/0000-0001-8928-8597
Schuster, Helen https://orcid.org/0009-0008-3824-3434
Heidinger, Martin
Muenst, Simone
Vetter, Marcus https://orcid.org/0009-0004-1003-1078
Kurzeder, Christian
Weber, Walter P
Bentires-Alj, Mohamed https://orcid.org/0000-0001-6344-1127
- License Information
-
More Information
Article History
Received: 3 March 2025
Revised: 17 October 2025
Accepted: 24 October 2025
First Online: 19 November 2025
Disclosure and competing interests statement
: MM, CJ, MK, JGM, MD, NK, KV, MMC, MP, AR, AS, YB, BH, HS, MH, SM, MV, CK, WPW, and MBA declare no competing financial interests. MK is a co-founder of RXcel GmbH. MBA owns equities in and has received laboratory support and compensation from Novartis and has served as a consultant for Basilea. MBA is an editorial advisory board member. WPW received research support from Agendia, paid to the University Hospital Basel for the TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101). MV is receiving grants from Swiss Cancer Research; Roche, GSK, ExactScience, personal fees and nonfinancial support from GSK Consumer Healthcare, AstraZeneca, Novartis Roche; and personal fees from Genomic Health, Eli Lilly and Company, Merck, MSD, Pfizer, and Daichii Sankyo, ASC Oncology outside the submitted work. SM reported receiving speaker fees from GSK Consumer Healthcare and advisory board fees from Novartis and Diaceutics outside the submitted work. CK received consulting fees from GSK, AstraZeneca, Novartis, Roche, Eli Lilly S.A., Pfizer, Genomic Health, Merck MSD, Novartis, PharmaMar, Tesaro; sits on advisory boards of GSK, AstraZeneca, Novartis, Roche, Eli Lilly S.A., Pfizer, Genomic Health, Merck MSD, Novartis, PharmaMar, Tesaro; received travel support from GSK, AstraZeneca, Roche.
